Dr. Andrew Branagan, MD
Claim this profileMassachusetts General Hospital
Area of expertise
Multiple Myeloma
Andrew Branagan, MD has run 6 trials for Multiple Myeloma.
Waldenstrom's Macroglobulinemia
Andrew Branagan, MD has run 3 trials for Waldenstrom's Macroglobulinemia. Some of their research focus areas include:
Affiliated Hospitals
Massachusetts General Hospital
Massachusetts General Hospital Cancer Center
Clinical Trials Andrew Branagan, MD is currently running
Zanubrutinib + Bendamustine + Rituximab
for Waldenstrom Macroglobulinemia
The purpose of this study is to determine the very good partial response (VGPR) or better rate in participants with Waldenström macroglobulinemia (WM). The names of the study drugs involved in this study are as follows: zanubrutinib, bendamustine, and rituximab.
Recruiting
1 award
Phase 2
7 criteria
CB-011
for Multiple Myeloma
This is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that targets the B cell maturation antigen (BCMA), to determine the best dose of CB-011, and to assess the effectiveness of CB-011 in treating multiple myeloma that has come back (relapsed) or that is no longer responding to other treatment (refractory).
Recruiting
1 award
Phase 1
4 criteria
More about Andrew Branagan, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Andrew Branagan, MD has experience with
- Dexamethasone
- Daratumumab
- Bortezomib
- Carfilzomib
- Pomalidomide
- Venetoclax
Breakdown of trials Andrew Branagan, MD has run
Multiple Myeloma
Waldenstrom's Macroglobulinemia
Waldenstrom Macroglobulinemia
Relapse
MYD88 Gene Mutation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Branagan, MD specialize in?
Andrew Branagan, MD focuses on Multiple Myeloma and Waldenstrom's Macroglobulinemia. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Andrew Branagan, MD currently recruiting for clinical trials?
Yes, Andrew Branagan, MD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Andrew Branagan, MD has studied deeply?
Yes, Andrew Branagan, MD has studied treatments such as Dexamethasone, Daratumumab, Bortezomib.
What is the best way to schedule an appointment with Andrew Branagan, MD?
Apply for one of the trials that Andrew Branagan, MD is conducting.
What is the office address of Andrew Branagan, MD?
The office of Andrew Branagan, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02117 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.